Endoscopic treatment of bleeding ulcers: Has everything been said and done?

X. Calvet, M. Vergara, E. Brullet

Producció científica: Contribució a revistaArticleRecercaAvaluat per experts

1 Citació (Scopus)

Resum

Endoscopic treatment reduces bleeding recurrence, the need for surgery and mortality in patients with bleeding ulcers. However endoscopic treatment fails in 10-15% of patients, leading to high morbidity and mortality. The therapeutic measures with demonstrated effectiveness in reducing the risk of hemorrhagic recurrence and its complications are combined endoscopie treatment (adrenaline plus a second hemostatic intervention) and proton pump inhibitors. Also useful, although there is less evidence, are immediate resuscitation and «second look» endoscopy. Some studies suggest that activated recombinant factor VII infusion or supra-selective arterial embolization can be useful in severe hemorrhage. Further studies are required to determine optimal treatment according to the characteristics of each patient.
Idioma originalAnglès
Pàgines (de-a)347-353
RevistaGastroenterologia y Hepatologia
Volum28
Número6
DOIs
Estat de la publicacióPublicada - 1 de gen. 2005

Fingerprint

Navegar pels temes de recerca de 'Endoscopic treatment of bleeding ulcers: Has everything been said and done?'. Junts formen un fingerprint únic.

Com citar-ho